![]() centrose centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells. | NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | ||
Founding Date | Founding Date 2013 | Founding Date 2007 | Founding Date 2011 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Dallas, US HQ | Locations Middleton, US HQ | Locations Gaithersburg, US HQ |
Employees | Employees 241100% increase | Employees N/A | Employees 5032% decrease |
Valuation ($) | Valuation ($) 37.6 m | Valuation ($) N/A | Valuation ($) 372.4 k |
Financial | |||
Net income | Net income ($17.1m) (FY, 2025) | Net income N/A | Net income ($32.3m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 4.7m | Total funding raised $ 100k | Total funding raised $ 33.8m |

centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells.
View companyNexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View company